Ayurveda Drug Trial In Haemorrhoids

To Evaluate The Effect of Apamarga Ksharodak Injection Submucosally In Grade I and Grade II Haemorrhoids - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079320

Enrollment

Registered

2025-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K649- Unspecified hemorrhoids

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged in between 18- 70 years Internal haemorrhoids Bleeding per rectum, pruritis, pain, discharge

Exclusion criteria

Exclusion criteria: CA rectum Prolapsed and Thrombosed pile mass Not suffering from any other systemic diseases Hypertrophid anal papilla Grade 3rd and 4th degree haemorrhoids History of haemorrhoid surgery or perianal surgery Combination of other anal diseases Pregnant or lactating women Patients on prolonged medication

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Apamarga ksharodak Injection(AKI) submucosally in Grade I and Grade II haemorrhoids. Standardization of the Apamarga Ksharodak Injection. To evaluate the rate of recurrence and complications.Timepoint: 1month	—

Secondary

Measure	Time frame
Standardisation of apamarga ksharodak injection To evaluate the rate of recurrence & complications.Timepoint: admitted for 5 days 7 days 15 days 1month	—

Countries

India

Contacts

Public ContactDr SK Mishra

Bananas Hindu University

rashmi.gupta@bhu.ac.in8299612869

Outcome results